Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P14784 (
IL-2 receptor
)
3,849
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Variable immunobiological changes occur with alcohol consumption. Previous studies have shown that
acetaldehyde
forms stable adducts with serum proteins, including albumin. These adducts are elevated in persons and animals consuming ethanol. We examined the effect of serum protein-
acetaldehyde
adducts formed with fetal bovine serum (FBS) on concanavalin A-stimulated murine splenocytes. Interleukin-2 (IL-2) secretion and
IL-2 receptor
(IL-2R) expression were determined as a function of the effect of the
acetaldehyde
-protein adduct(s). FBS was incubated with
acetaldehyde
(500, 100, 50, 25, 10, and 0 microM) for 1 hr at 37 degrees C. Excess
acetaldehyde
was removed by ultrafiltration using a 500 molecular weight cut-off membrane in 3 volumes. Free as well as bound
acetaldehyde
was quantified using fluorigenic HPLC before and after incubation. Recovered
acetaldehyde
correlated with the amount added (r2 = 0.996). Splenocytes were cultured for 48 hr in complete medium containing 5%
acetaldehyde
-treated and 5% untreated FBS with 4 micrograms/ml concanavalin A. Although cell viability was unchanged,
acetaldehyde
-treated FBS mixed with native FBS decreased IL-2 secretion in a dose-dependent manner. The percentage of cells expressing IL-2R was reduced only at the highest
acetaldehyde
-FBS dose. Therefore, immunological effects ascribed to ethanol may result in part from the toxic properties of
acetaldehyde
-protein adducts on IL-2 secretion.
...
PMID:Acetaldehyde-serum protein adducts inhibit interleukin-2 secretion in concanavalin A-stimulated murine splenocytes: a potential common pathway for ethanol-induced immunomodulation. 762 67